Table 4.

Multiviariable Analysis of Survival Outcome

Parameter	Level	Reference level	Hazard Ratio	95%CI for HR		P-value (compare to the reference level)	P-value (variable effect)
Dose	>=800	<800	1.855	1.021	3.372	0.0426	0.0426
risk_donor	HR_CR2 Cord	VHR_CR1 Other	1.342	0.562	3.204	0.5076	0.0074
	HR_CR2 Matched	VHR_CR1 Other	1.069	0.455	2.508	0.8787
	HR_CR2 Other	VHR_CR1 Other	0.955	0.393	2.317	0.9186
	IR_CR2 Matched	VHR_CR1 Other	0.240	0.065	0.892	0.0331
	VHR_CR1 Matched	VHR_CR1 Other	0.247	0.082	0.740	0.0125

Multivariate survival model include dose level, fieldname, position, disease risk group and donor type,

TacroMTX versus MacroMTX and Sirolimus treatment, MRD at 0.10% level.

Abbreviations: PFS-Progression-free survival, OS-overall survival; HR-high risk; IR-intermediate risk; CR-complete remission; VHR-very high risk;